Log In
Print
BCIQ
Print
Print this Print this
 

PHT101 (PGC-C12E-Terlipressin)

  Manage Alerts
Collapse Summary General Information
Company PharmaIN Corp.
DescriptionAnalogue of vasopressin using Protected Graft Copolymer (PCG) delivery technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCirrhosis
Indication DetailsTreat ascites due to all etiologies except cancer
Regulatory Designation

U.S. - Orphan Drug (Treat ascites due to all etiologies except cancer)

Partner

LAT Pharma LLC


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today